Heckert, A., Dahal, L., Tjian, R
"Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid"
Huang M, Wei R, Wang Y, Su T, Li Q, Yang X, et al
Limitations of Use: Compounded semaglutide should not be used in combination with other semaglutide-containing products or any other GLP-1 receptor agonist The safety and efficacy of coadministration with other products for weight loss have not been established Compounded semaglutide has not been studied in patients with a history of pancreatitis Note: Compounded medications are not FDA approved and do not have indications for treatment as an FDA approved medication would
But medicine moves slowly when infant safety is involved, and that caution, while frustrating for mothers who want definitive answers, is appropriate